Lupin gets MHRA approval for 'Lisinopril' in UK

Mumbai, July 2: Pharma major Lupin Ltd today announced that it has received an approval for its generic 'Lisinopril' tablets of 2.5 mg, 5 mg, 10 mg and 20 mg from the Medicines and Healthcare products Regulatory Agency (MHRA) of UK.

Lisinopril is an ACE inhibiting drug used for treating hypertension and congestive heart failure.

Lisinopril tablets would be the generic equivalent of Merck's 'Prinivil' tablets. Sales of Prinivil tablets in UK are close to USD 46 million as per IMS. Commercial shipments are planned shortly.

Lupin Ltd managing director Dr Kamal Sharma, in a statement here today, said ''The MHRA approval of Lisinopril tablets is our first oral generic product approval in UK. We are market leaders in this molecule in the US and we hope to emulate our success in Europe as well. This approval is the first of a series of approvals that we expect in UK and Europe in the next few months,''

UNI